RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
A collaborative effort led by Professor Wanli Liu 's team at Tsinghua University has uncovered a sophisticated mechanism by which keratinocytes, the predominant cell type in the skin's epidermis, ...
The skin is far more than a simple physical barrier. These two researches address a fundamental question in immunology: How does a localized skin ...
Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance ...
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
With the prevalence of infectious diseases, the rapid assessment of population-specific immune protection has become important for public health. A ...
Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.
Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...
The bispecific T-cell engager talquetamab (Talvey) has some distinct adverse events (AEs) compared with drugs of the same class that target B-cell maturation antigen (BCMA) in mul ...
A futuristic “DNA origami” vaccine platform may one day outperform mRNA shots while being easier to produce and distribute. Credit: Shutterstock Scientists have developed a new DNA origami–based ...